|
|
Article: INVO Bioscience Announces Clinical Results of Initial INVO Procedures in Latin America.(Financial report)
- Article from:
- Chemicals & Chemistry
- Article date:
- November 13, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
INVO Bioscience announced that CECOLFES (http://cecolfes.com/), Colombia Fertility Center, Bogota, Colombia, the first center in Latin America to introduce the INVOcell device and the INVO procedure for treatment of infertility, made known today the results of the first 28 cycles of the INVO procedure. Of the 28 patients treated, 27 patients had embryos transferred and 10 patients became pregnant with only one patient having a multiple pregnancy. This results in a 36% ongoing pregnancy rate per cycle. The average patient age was 34 years old with an average number of 6 oocytes (eggs) retrieved per patient. "We are very happy with these initial results and the patients love ...